# Real-world Trial of Individualized Precision Oncology

> **NCT07346209** · PHASE2 · NOT_YET_RECRUITING · sponsor: **University of California, San Diego** · enrollment: 280 (estimated)

## Conditions studied

- Metastatic Cancer
- Unresectable Carcinoma

## Interventions

- **DRUG:** Molecularly matched therapy
- **DRUG:** Standard of care

## Key facts

- **NCT ID:** NCT07346209
- **Lead sponsor:** University of California, San Diego
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-06
- **Primary completion:** 2031-03
- **Final completion:** 2031-09
- **Target enrollment:** 280 (ESTIMATED)
- **Last updated:** 2026-04-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07346209

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07346209, "Real-world Trial of Individualized Precision Oncology". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT07346209. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*